NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
This Quarter Return
-10.96%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$968M
AUM Growth
+$968M
Cap. Flow
-$154M
Cap. Flow %
-15.94%
Top 10 Hldgs %
92.21%
Holding
21
New
2
Increased
1
Reduced
3
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$526B
$294M 30.38% 2,979,100
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$199M 20.56% 4,910,487
INGN icon
3
Inogen
INGN
$216M
$172M 17.8% 3,549,320
VGK icon
4
Vanguard FTSE Europe ETF
VGK
$26.8B
$103M 10.68% 2,101,000
NVRO
5
DELISTED
NEVRO CORP.
NVRO
$29M 3% 625,704 -900,000 -59% -$41.8M
TBRA
6
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$26M 2.69% 2,696,405
ADAP
7
Adaptimmune Therapeutics
ADAP
$15.6M
$16.9M 1.75% 1,411,567 -350,000 -20% -$4.19M
OTIC
8
DELISTED
Otonomy, Inc.
OTIC
$15.6M 1.61% 875,025
FLXN
9
DELISTED
Flexion Therapeutics, Inc.
FLXN
$15.4M 1.59% 1,033,131 -1,100,000 -52% -$16.3M
AKBA icon
10
Akebia Therapeutics
AKBA
$833M
$14.6M 1.51% 1,516,387
ELDN icon
11
Eledon Pharmaceuticals
ELDN
$155M
$12.8M 1.32% 1,238,252
CLCD
12
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$11.8M 1.22% 3,056,563
HTGM
13
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$9.76M 1.01% 1,280,185
NBRV
14
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$8.24M 0.85% +867,127 New +$8.24M
PEN icon
15
Penumbra
PEN
$10.6B
$4.21M 0.43% +104,944 New +$4.21M
GKOS icon
16
Glaukos
GKOS
$5.5B
$1.81M 0.19% 75,000
XENE icon
17
Xenon Pharmaceuticals
XENE
$2.98B
$1.05M 0.11% 127,563
AERI
18
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
-100,000 Closed -$1.77M
ALDR
19
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
-1,951,183 Closed -$103M